Update on Non-Hodgkin Lymphoma: Alignment of the Current Treatment Landscape and Value-Based Care

• RELEASE DATE: FEBRUARY 28, 2011 • EXPIRATION DATE: FEBRUARY 28, 2012
ESTIMATED TIME TO COMPLETE: 1.0 HOUR •

Download PDF

Click here to complete the posttest and obtain a CE certificate online

TARGET AUDIENCE

This activity was developed for pharmacists and other healthcare professionals practicing in a managed care environment.

LEARNING OBJECTIVES

After completing this activity, the reader should be able to:

• Explain the impact of key clinical data presented at ASH 2010 on payers and providers in the treatment and management of non-Hodgkin lymphoma (NHL)
• Identify patient/disease-associated factors, as well as economic factors that may affect the choice of a therapeutic agent and be able to formulate a management strategy using a riskadapted approach to the treatment of NHL
• Construct informed treatment decisions for the purpose of improving the long-term outlook for patients with NHL across the lifecycle of the disease
• Identify and discuss the future of NHL treatment and the potential clinical, business, and regulatory changes that could affect the cost-value benefit design

SPONSOR

This activity is jointly sponsored by the Medical Learning Institute, Inc. (a nonprofit medical accreditation company), and Center of Excellence Media, LLC.

INSTRUCTIONS FOR CREDIT

1. Read the article in its entirety
2. Select “Click here to complete the posttest and obtain a CE certificate online”
3. Complete and submit the CE posttest and CE Activity Evaluation
4. Print your Statement of Completion

For questions regarding the accreditation of this activity, please contact Medical Learning Institute, Inc., at 609-333-1693 or cgusack@mlicme.org.

PHARMACIST DESIGNATION

Medical Learning Institute, Inc., is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Completion of this activity provides for 1.0 contact hour (0.1 CEU) of continuing education credit. The universal activity number for this activity is 0468- 9999-11-003-H01-P.

FACULTY DISCLOSURES

Before the activity, all faculty will disclose the existence of any financial interest and/or relationship( s) they might have with the manufacturer(s) of any commercial product(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speaker’s bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

• John Fox, MD, and James T. Kenney, RPh, MBA, have nothing to disclose.
• Caroline Helwick has stock ownership at Micronet.

The associates of Medical Learning Institute, Inc., the accredited provider for this activity, and Center of Excellence Media, LLC, do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this CE activity for any amount during the past 12 months.

DISCLAIMER

The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

COMMERCIAL SUPPORT ACKNOWLEDGEMENT

This activity is supported by an educational grant from Genentech.